Biocon Biologics Receives FDA Approval for Denosumab Biosimilars Bosaya and Aukelso

Biocon Biologics Ltd. (BBL) announced that the U.S. FDA has approved Bosaya™ (denosumab-kyqq) and Aukelso™ (denosumab-kyqq), biosimilars of Prolia® an...